Earnings season is upon us; Makary on rare disease; Startup is first to inject CRISPR in the brain; and more
Welcome back to Endpoints Weekly! Our team of reporters covered first-quarter earnings results from a handful of companies this week. See below for pharma executives’ comments on tariff exposure, dealmaking and more. We also have ...
Welcome back to Endpoints Weekly! Our team of reporters covered first-quarter earnings results from a handful of companies this week. See below for pharma executives’ comments on tariff exposure, dealmaking and more. We also have ...
